Harvard Innovation Lab

Recursive Health Joins Harvard Innovation Labs Winter Cohort

Big Things are Happening!

We’re thrilled to announce that Recursive Health has been admitted into the prestigious Harvard Innovation Labs Winter Cohort. This incredible opportunity provides us with world-class mentorship, a powerful network, and structured programming designed to accelerate early product development and explore product-market fit.

Why This Matters

We've already seen strong early interest, but the support from Harvard Innovation Labs will elevate us to the next level. The resources we gain will help refine our solution and bring it to market faster.

In particular, we look forward to Harvard’s close link to Mass Brigham and Beth Israel Deaconess, two of the worlds leading healthcare and research organizations. It has been incredible even in just the first couple of weeks to feel the support of such proactive and passionate healthcare innovators.

The iLab provides:

• Access to top healthcare and tech minds to help us refine and scale Recursive Health including pilot sites and case studies.

• Connections to investors and industry leaders—vital for our next growth phase.

• Programming focused on product-market fit and go-to-market strategies to ensure we’re solving the right problem for the right people.

What’s Next?

The coming months will be pivotal. We’re launching our product MVP with early pilot sites and preparing to raise a pre-seed round of funding. We can’t wait to see the impact to patients as the first cohort complete their screening tests, taking steps toward earlier diagnosis and longer, healthier lives.

Onward!

Brandon C. Busuito, M.D., M.B.A.

Co-founder, CEO